Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

The company is a key player in China's hypercompetitive EV market, but has struggled to turn a profit amid rising competition ...

Sunday's race card from Sha Tin offers more than a dozen bet types, with fans able to wager into the World Pool ...

The developer wants to refinance $11 bln of loans but CEO Echo Huang has yet to reverse a 4-year revenue slump. Lenders ...

Hong Kong's legislature passed a stablecoin bill on Wednesday that establishes a licensing regime for fiat-referenced ...

Industry leaders say move will prevent delays in building 7,100 flats contracted to Aggressive Construction Company, whose ...

Several news outlets have been unreasonably subjected to tax investigations, according to the city’s journalists’ association ...

European and Asian investors have pumped record sums into global equity funds that exclude the US market, and shares in ...

Chinese battery giant Contemporary Amperex Technology’s shares soared Tuesday in their Hong Kong debut, marking the world’s ...

BYD Co.’s shares rose to a record high in Hong Kong, expanding their premium over those trading on the mainland to the ...

With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor ...

ProWine Hong Kong 2025 concluded successfully at the Hong Kong Convention and Exhibition Center. Against the backdrop ...